Edition:
United States

Theratechnologies Inc (TH.TO)

TH.TO on Toronto Stock Exchange

6.81CAD
14 Dec 2017
Change (% chg)

$0.01 (+0.15%)
Prev Close
$6.80
Open
$6.76
Day's High
$6.95
Day's Low
$6.65
Volume
64,010
Avg. Vol
94,586
52-wk High
$8.72
52-wk Low
$2.61

Chart for

About

Theratechnologies Inc. is a specialty pharmaceutical company. The Company addresses medical needs to promote healthy living among human immunodeficiency virus (HIV) patients. Its products include EGRIFTA and Ibalizumab. EGRIFTA (tesamorelin for injection) refers to tesamorelin and it is indicated for the reduction of excess... (more)

Overall

Beta: 1.58
Market Cap(Mil.): $510.45
Shares Outstanding(Mil.): 74.96
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.50 16.04
EPS (TTM): -- -- --
ROI: -- 15.11 35.70
ROE: -- 16.59 15.40

BRIEF-Theratechnologies Q3 loss per share c$0.04

* Theratechnologies announces financial results for third quarter of 2017

Oct 05 2017

BRIEF-Theratechnologies announces new findings with investigational Antiretroviral Ibalizumab, with EGRIFTA

* Theratechnologies Inc - announces new findings with investigational Antiretroviral Ibalizumab and with EGRIFTA

Jul 24 2017

BRIEF-Theratechnologies reports Q2 loss per share C$0.13

* Theratechnologies announces financial results for second quarter of 2017

Jul 12 2017

BRIEF-Theratechnologies says FDA sets PDUFA date of Jan 3 for ibalizumab application

* FDA grants priority review to HIV monoclonal antibody and long-acting investigational antiretroviral ibalizumab

Jun 30 2017

Earnings vs. Estimates